Fore Pharma announced the results of its Atopic Dermatitis patients study in a new report ‘Europe Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2017’.
The report provides insights into Atopic Dermatitis epidemiology, Atopic Dermatitis diagnosed patients, and Atopic Dermatitis treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Atopic Dermatitis derived from epidemiological analysis, percentage of patients diagnosed with Atopic Dermatitis, and percentage of patients treated with a therapy.
The study helps executives estimate Atopic Dermatitis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Atopic Dermatitis prevalence, Atopic Dermatitis diagnosis rate, and Atopic Dermatitis treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.
Key Features of the Report: - Atopic Dermatitis Patient Flow - Atopic Dermatitis Prevalence - Atopic Dermatitis Diagnosed Patients - Atopic Dermatitis Treated Patients
Our reports have been used by over 10K customers, including:
Pigmentation Disorders Treatment Market Research Report by Indication (Hyperpigmentation and Hypopigmentation), by Treatment & Therapies (Chemical Peels, Dermabrasion, Laser Resurfacing, and Melasma), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market...
Dermatitis (Eczema) Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Dermatitis (Eczema) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Dermatitis (Eczema) Clinical trials scenario. This report provides top line data relating to the clinical...
Atopic Dermatitis Drugs Market Research Report by Route of Administration (Injectable ROA, Oral ROA, and Tropical ROA), by Drug Class (Biologics, Calcineurin Inhibitors, Corticosteroids, and PDE4 Inhibitors) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing...
The South and Central America dermatology treatment devices market is expected to reach US$ 695.21 million in 2027 from US$ 451.35million in 2019. The market is estimated to grow with a CAGR of 5.7% from 2020 to 2027. The growth of this market is attributed to the key driving factors such as higher prevalence of skin conditions and melanoma...
‘Palmar Hyperhidrosis Market Insights, Epidemiology, and Market Forecast – 2030’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends of Palmar Hyperhidrosis in the United States. The Palmar Hyperhidrosis market report provides analysis regarding current treatment...
‘Palmar Hyperhidrosis – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical, and forecasted Palmar Hyperhidrosis epidemiology in the United States. Geographies Covered • The United States Study Period: 2017–2030 Palmar Hyperhidrosis: Understanding The...